Nanogap Therapeutics

We are developing a novel treatment for mutant KRAS cancer, which is 30% of all cancers and is resistant to current therapies .

  • Stage Product In Development
  • Industry Biotechnology
  • Location Santiago de Compostela, Spain
  • Currency EUR
  • Founded July 2019
  • Employees 2
  • Incorporation Type Other
  • Website nanpgaptherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free